For the quarter ending 2026-03-31, PBYI has $192,699K in assets. $64,283K in debts. $36,193K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 36,193 | 29,635 | 53,525 | 54,662 |
| Marketable securities | 65,352 | 67,893 | 40,863 | 41,362 |
| Accounts receivable | 26,329 | 53,654 | 33,565 | 25,910 |
| Inventory | 8,693 | 5,515 | 9,476 | 8,591 |
| Prepaid expenses, current | 3,405 | 3,642 | 3,830 | 3,889 |
| Restricted cash, current | 2,091 | 2,091 | 2,091 | 2,091 |
| Other assets, current | 196 | 256 | 230 | 73 |
| Total current assets | 142,259 | 162,686 | 143,580 | 136,578 |
| Lease right-of-use assets, net | 4,574 | 5,373 | 6,147 | 2,828 |
| Property, plant and equipment, gross | - | 4,785 | 6,894 | - |
| Less accumulated depreciation | - | 4,598 | 6,589 | - |
| Property and equipment, net | 124 | 187 | 305 | 388 |
| Intangible assets, net | 38,957 | 41,392 | 43,827 | 46,262 |
| Restricted cash, long-term | - | 0 | 0 | 0 |
| Deferred tax assets | 3,830 | 3,830 | 7,075 | 7,075 |
| Prepaid expenses and other, long-term | 2,955 | 2,834 | 1,928 | 1,785 |
| Total assets | 192,699 | 216,302 | 202,862 | 194,916 |
| Accounts payable | 8,166 | 5,056 | 6,386 | 5,424 |
| Accrued expenses | 38,378 | 50,031 | 37,116 | 31,797 |
| Lease liabilities, current | 125 | 1,314 | 2,470 | 4,364 |
| Post-marketing commitment liability | 1,684 | 2,187 | 2,858 | 3,294 |
| Current portion of long-term debt | 11,283 | 22,523 | 33,716 | 33,997 |
| Other liabilities, current | 101 | 142 | 182 | 223 |
| Post-marketing commitment liability, long-term | - | 0 | 0 | 230 |
| Total current liabilities | 59,737 | 81,253 | 82,728 | 79,099 |
| Total long-term debt, net | - | 0 | 0 | 10,869 |
| Other liabilities, long-term | - | 0 | 0 | 0 |
| Lease liabilities, long-term | 4,546 | 4,709 | 4,866 | 0 |
| Total liabilities | 64,283 | 85,962 | 87,594 | 90,198 |
| Common stock - .0001 par value per share 100,000,000 shares authorized 50,879,204 shares issued and outstanding at march 31, 2026 and 50,408,023 issued and outstanding at december 31, 2025 | 5 | 5 | 5 | 5 |
| Additional paid-in capital | 1,415,970 | 1,414,074 | 1,412,457 | 1,410,784 |
| Accumulated other comprehensive (loss) income | -31 | 36 | 19 | -14 |
| Accumulated deficit | -1,287,528 | -1,283,775 | -1,297,213 | -1,306,057 |
| Total stockholders equity | 128,416 | 130,340 | 115,268 | 104,718 |
| Total liabilities and stockholders equity | 192,699 | 216,302 | 202,862 | 194,916 |
PUMA BIOTECHNOLOGY, INC. (PBYI)
PUMA BIOTECHNOLOGY, INC. (PBYI)